Nature Reviews Drug Discovery 11, 790–811 (2012)
On page 7 of the main text, LY2382770 was incorrectly referred to as a pan-TGFβ ligand-specific blocking antibody; it is a TGFβ1 ligand-selective blocking antibody. This has now been corrected online.
Additional information
The online version of the original article can be found at 10.1038/nrd3810
Rights and permissions
About this article
Cite this article
Akhurst, R., Hata, A. Erratum: Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov 11, 886 (2012). https://doi.org/10.1038/nrd3878
Published:
Issue date:
DOI: https://doi.org/10.1038/nrd3878
